Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 5;13:43–58. doi: 10.2147/POR.S360044

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Hancock et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

(A) Exacerbation frequency as per GINA treatment intensity for the total study population as per electronic medical records. (B) Exacerbation frequency as per GINA treatment intensity for the questionnaire respondents as per electronic medical records. (C) Exacerbation frequency as per GINA treatment intensity as self-reported by questionnaire respondents. GINA 1 is defined as, as needed short acting beta agonists; GINA 2 is defined as only low dose inhaled corticosteroids (ICS); GINA 3 is defined as ICS only at a moderate dose or ICS/long-acting beta agonist (LABA) combination at a low dose; GINA 4 is defined as ICS at a high dose or ICS/LABA at a moderate dose; GINA 5a is defined as ICS at a high dose; 5b is defined as biologics or chronic oral corticosteroid therapy.

Abbreviations: GINA, Global Initiative for Asthma; EMR, electronic medical records; OCS, oral corticosteroids.